Dendritic cell targeting using a DNA vaccine induces specific antibodies and CD4+ T cells to the dengue virus envelope protein Domain III (2019)
- Authors:
- USP affiliated authors: YAMAMOTO, MARCIO MASSAO - ICB ; FERREIRA, LUIS CARLOS DE SOUZA - ICB ; BOSCARDIN, SILVIA BEATRIZ - ICB ; ZANETI, ARTHUR BARUEL - ICB ; SULCZEWSKI, FERNANDO BANDEIRA - ICB ; ALMEIDA, BIANCA DA SILVA - ICB ; SOUZA, HIGO FERNANDO SANTOS - ICB ; FERREIRA, NATÁLIA SOARES - ICB ; MAEDA, DENICAR LINA NASCIMENTO FABRIS - ICB ; SALES, NATIELY SILVA - ICB
- Unidade: ICB
- DOI: 10.3389/fimmu.2019.00059
- Subjects: PARASITOLOGIA; MICROBIOLOGIA; CÉLULAS DENDRÍTICAS; VACINAS VIRAIS; DNA VIRAL; DENGUE
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Immunology
- ISSN: 1664-3224
- Volume/Número/Paginação/Ano: v. 10, art. 59, p. 1-15, 2019
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
ZANETI, Arthur Baruel et al. Dendritic cell targeting using a DNA vaccine induces specific antibodies and CD4+ T cells to the dengue virus envelope protein Domain III. Frontiers in Immunology, v. 10, p. 1-15, 2019Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2019.00059. Acesso em: 28 dez. 2025. -
APA
Zaneti, A. B., Yamamoto, M. M., Sulczewski, F. B., Almeida, B. da S., Souza, H. F. S., Ferreira, N. S., et al. (2019). Dendritic cell targeting using a DNA vaccine induces specific antibodies and CD4+ T cells to the dengue virus envelope protein Domain III. Frontiers in Immunology, 10, 1-15. doi:10.3389/fimmu.2019.00059 -
NLM
Zaneti AB, Yamamoto MM, Sulczewski FB, Almeida B da S, Souza HFS, Ferreira NS, Maeda DLNF, Sales NS, Rosa DS, Ferreira LC de S, Boscardin SB. Dendritic cell targeting using a DNA vaccine induces specific antibodies and CD4+ T cells to the dengue virus envelope protein Domain III [Internet]. Frontiers in Immunology. 2019 ; 10 1-15.[citado 2025 dez. 28 ] Available from: https://doi.org/10.3389/fimmu.2019.00059 -
Vancouver
Zaneti AB, Yamamoto MM, Sulczewski FB, Almeida B da S, Souza HFS, Ferreira NS, Maeda DLNF, Sales NS, Rosa DS, Ferreira LC de S, Boscardin SB. Dendritic cell targeting using a DNA vaccine induces specific antibodies and CD4+ T cells to the dengue virus envelope protein Domain III [Internet]. Frontiers in Immunology. 2019 ; 10 1-15.[citado 2025 dez. 28 ] Available from: https://doi.org/10.3389/fimmu.2019.00059 - Conventional type 1 dendritic cells induce TH1, TH1‐like follicular helper T cells and regulatory T cells after antigen boost via DEC205 receptor
- Reactivity of DENV-positive sera against recombinant envelope proteins produced in bacteria and eukaryotic cells
- STAT6 signaling pathway controls germinal center responses promoted after antigen targeting to conventional type 2 dendritic cells
- STAT3 signaling modulates the immune response induced after antigen targeting to conventional type 1 dendritic cells through the DEC205 receptor
- Antibody cross-reactivity and evidence of susceptibility to emerging Flaviviruses in the dengue-endemic Brazilian Amazon
- A DNA vaccine targeting the dengue virus envelope protein domain III to dendritic cells improves humoral and cellular immune responses
- Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge
- Antigen targeting to dendritic cells allows the identification of a CD4 T-cell epitope within an immunodominant Trypanosoma cruzi antigen
- Cytotoxic anti-circumsporozoite antibodies target malaria sporozoites in the host skin
- Type 1 and 2 mouse spleen conventional dendritic cells differentially prime T helper cells after antigen targeting via DEC205 and DCIR2 receptors
Informações sobre o DOI: 10.3389/fimmu.2019.00059 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
Dendritic cell targeting ... | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
